Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

(2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide

EU orphan designation number: EU/3/14/1372   
Active ingredient: (2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide
Indication: Treatment of microscopic polyangiitis
Sponsor: Chemocentryx Ireland Limited
70 Sir John Rogerson's Quay, Dublin 2, Co. Dublin, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/11/2014 Orphan designation EMA/OD/149/14 (2014)8868 of 19/11/2014
16/09/2016 Change of name and/or address of sponsor
25/02/2019 Transfer of orphan designation EMA/OD/0000004218 (2019)1620 of 21/02/2019